Linear ablation at the mitral isthmus following mitral valve surgery

Abstract Background Creating a conduction block along the mitral isthmus (MI) can be challenging due to anatomical factors. Ethanol infusion into the vein of Marshall (EIVOM) has proven effective in facilitating this process. Patients with previous mitral valve surgery (MVS) are at high risk of atrial fibrillation (AF) and atrial tachycardia (AT). Feasibility and outcome of EIVOM and MI ablation in MVS patients remain unknown. Objectives This study sought to evaluate the feasibility, safety and durability of EIVOM and MI in MVS patients. Methods A total of 54 consecutive MVS patients undergoing EIVOM and MI ablation were retrospectively included in this study. We evaluated the feasibility and efficacy of EIVOM and MI ablation. Results Mean age was 64±12 years, 46.3% were female and the mean left atrial volume index was 56±18 ml/m². Catheter ablation (CA) was performed within a mean of 12±11 years after MVS. MV surgery was replacement in 74% of patients and annuloplasty in the remaining 26%. Of note, 8% had a concomitant Maze and/or a prior CA for pulmonary vein isolation (PVI). However, only 6 Patients (11.1%) had an attempted mitral isthmus ablation during index surgery. EIVOM was successful with no complications in 92.6% of the patients using 9.5±2.2ml of Ethanol 96% with a mean procedure time of 24±15 minutes. MI conduction block could be achieved in 88.9% with the epicardial ablation via the coronary sinus needed in 94.4% of the patients. A subgroup analysis was conducted to compare outcomes between MV replacement and MV annuloplasty, revealing no significant difference in EIVOM success (95% vs. 85.7%, p=0.58) or rates of acute MI block (90% vs. 86%, p=0.64). An additional subgroup analysis examined MI acute block rates between patients with prior Maze and/or catheter ablation (CA) procedures versus those without, also finding no significant difference (92% vs. 85.2%, p=0.67). Conclusion Among patients with previous mitral valve surgery, performing a durable mitral isthmus line facilitated by ethanol infusion into the vein of Marshall is feasible and acutely successful.

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2025-05-01
DOI
https://doi.org/10.1093/europace/euaf085.124
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Linear ablation at the mitral isthmus following mitral valve surgery

Josselin Duchâteau, Karim Bénali, Cinzia Monaco, Marine Arnaud et al.
EP Europace
Cardiac Valve Diseases and Treatments
article

Linear ablation at the mitral isthmus following mitral valve surgery

Josselin Duchâteau, Karim Bénali, Cinzia Monaco, Marine Arnaud, F. Sacher, M. Hocini, Romain Tixier, Thomas Pambrun, Benjamin Bouyer, Konstantinos Vlachos, M. Yokoyama, N. Moussaoui, Kinan Kneizeh, N. Derval, P. Jaïs
article en

Abstract

Abstract Background Creating a conduction block along the mitral isthmus (MI) can be challenging due to anatomical factors. Ethanol infusion into the vein of Marshall (EIVOM) has proven effective in facilitating this process. Patients with previous mitral valve surgery (MVS) are at high risk of atrial fibrillation (AF) and atrial tachycardia (AT). Feasibility and outcome of EIVOM and MI ablation in MVS patients remain unknown. Objectives This study sought to evaluate the feasibility, safety and durability of EIVOM and MI in MVS patients. Methods A total of 54 consecutive MVS patients undergoing EIVOM and MI ablation were retrospectively included in this study. We evaluated the feasibility and efficacy of EIVOM and MI ablation. Results Mean age was 64±12 years, 46.3% were female and the mean left atrial volume index was 56±18 ml/m². Catheter ablation (CA) was performed within a mean of 12±11 years after MVS. MV surgery was replacement in 74% of patients and annuloplasty in the remaining 26%. Of note, 8% had a concomitant Maze and/or a prior CA for pulmonary vein isolation (PVI). However, only 6 Patients (11.1%) had an attempted mitral isthmus ablation during index surgery. EIVOM was successful with no complications in 92.6% of the patients using 9.5±2.2ml of Ethanol 96% with a mean procedure time of 24±15 minutes. MI conduction block could be achieved in 88.9% with the epicardial ablation via the coronary sinus needed in 94.4% of the patients. A subgroup analysis was conducted to compare outcomes between MV replacement and MV annuloplasty, revealing no significant difference in EIVOM success (95% vs. 85.7%, p=0.58) or rates of acute MI block (90% vs. 86%, p=0.64). An additional subgroup analysis examined MI acute block rates between patients with prior Maze and/or catheter ablation (CA) procedures versus those without, also finding no significant difference (92% vs. 85.2%, p=0.67). Conclusion Among patients with previous mitral valve surgery, performing a durable mitral isthmus line facilitated by ethanol infusion into the vein of Marshall is feasible and acutely successful.

EP EuropaceVol. 27(Supplement_1)
Hôpital Cardiologique du Haut-Lévêque (FR)
Openalex Percentile: Top 79%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.